← European Medicine Shortage Tracker · all medicines
Fluorescein-Natrium (Ph.Eur.); Oxybuprocainhydrochlorid currently has availability issues reported in 1 European register: Germany.
Shortage ATC S01HA30 · also listed as: Fluorescein-Natrium (Ph.Eur.); Oxybuprocainhydrochlorid · data refreshed 7 August 2026
As of 7 August 2026, 1 of the 10 tracked registers list current availability issues for Fluorescein-Natrium (Ph.Eur.); Oxybuprocainhydrochlorid, covering 1 affected product presentation. The longest-running open report was filed in Germany on 2026-05-19 and has now been open for about 3 months. Where agencies state a cause, manufacturing problems lead with 1 of the 1 stated-cause reports. The furthest expected-resolution date currently on file is 2026-09-03; the earliest is 2026-09-03. Registers in Germany indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching. In the WHO ATC classification, Fluorescein-Natrium (Ph.Eur.); Oxybuprocainhydrochlorid is coded S01HA30 — a medicine acting on sensory organs — so clinically related products appear under “Related medicines” below.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇩🇪 Germany | Shortage Thilorbin | 2026-05-19 | 2026-09-03 | Probleme in der Herstellung Alternatives: N/A | register ↗ |
Every individual register entry for Fluorescein-Natrium (Ph.Eur.); Oxybuprocainhydrochlorid in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇩🇪 DE | Thilorbin | Shortage | 2026-05-19 | 2026-09-03 | Probleme in der Herstellung |
Yes. As of 7 August 2026, availability issues are reported in: Germany. Availability is national — a shortage in one country does not mean it is short everywhere.
Agency prognoses on file range from 2026-09-03 to 2026-09-03. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.
1 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency register that lists Fluorescein-Natrium (Ph.Eur.); Oxybuprocainhydrochlorid: BfArM (Germany). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Fluorescein-Natrium (Ph.Eur.); Oxybuprocainhydrochlorid — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/fluorescein-natrium-ph-eur-oxybuprocainhydrochlorid/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Fluorescein-Natrium (Ph.Eur.); Oxybuprocainhydrochlorid availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/fluorescein-natrium-ph-eur-oxybuprocainhydrochlorid/">Fluorescein-Natrium (Ph.Eur.); Oxybuprocainhydrochlorid shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>